MedTrace Logo

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS

NCT05933291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2023-07-06

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effect of steroid therapy in patients with COVID-19 ARDS. The main questions it aims to answer are:

* Differences between patients with COVID-19 ARDS before and after steroid treatment in BALF single cell landscape, as well as patients with different prognosis.
* Differences between COVID-19 and non COVID-19 ARDS patients in BALF single cell landscape.

Participants will Choose whether to use or not to utilize steroid treatment based on conditions.

Conditions

  • ARDS: Acute Respiratory Distress Syndrome
  • Covid19

Interventions

DRUG

steroid

Moderate- or high-dose steroids

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Yun Long, MD · Peking union medical college hospital, ICU department

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-24
Primary Completion
2023-02-09
Completion
2023-03-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05933291 on ClinicalTrials.gov